Affordable Access

Publisher Website

Overview of biologic therapies in autoimmune rheumatic diseases

Authors
Journal
Medicine
1357-3039
Publisher
Elsevier
Volume
42
Issue
3
Identifiers
DOI: 10.1016/j.mpmed.2013.12.008
Keywords
  • Anti-Tnf
  • Autoimmune Rheumatic Diseases
  • Biologic Agents
  • Efficacy
Disciplines
  • Biology
  • Medicine

Abstract

Abstract First-line treatment of autoimmune rheumatic diseases (ARD) ranging from systemic lupus erythematosus (SLE), through small and large vessel vasculitides to Behçet's syndrome, is still based upon the use of traditional immunosuppressive drugs. Increasingly, the newly developed biologic agents are used as second-line treatments of these diseases. This summary article highlights the biologic agents that are used in clinical practice as well as their indications, contraindications and adverse effect profiles. Efficacy of these biologic agents is tabulated in accordance with current evidence of open-label studies and trials, and new advances in the biologic treatment of several ARDs are also discussed. Overall, this paper highlights the contribution that the biologic therapies have made to progressive advancements in the treatment of ARD.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Biological therapies in rheumatic diseases.

on La Clinica terapeutica 2013

[Biologic therapies in autoimmune diseases].

on Arerugī = [Allergy] February 2015

Biologic therapies in autoimmune diseases.

on Clinical medicine (London, Eng... 2006

Biological therapies of autoimmune diseases.

on Current drug targets. Inflamma... February 2005
More articles like this..